Heyman Tomas J.
CIK 0001814673
Director
Filings
18
Latest May 29, 2026
Issuers covered
5
Showing
18 of 18
Page 1
Track record
1 of 2 open-market trades scored (50% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +7.7% | +7.7% | +7.7% | +7.7% |
| 90 days | 1 | 100% | +14.2% | +14.2% | +14.2% | +14.2% |
| 180 days | 1 | 100% | +3.0% | +3.0% | +3.0% | +3.0% |
| 365 days | 1 | 0% | -13.6% | -13.6% | -13.6% | -13.6% |
Issuers
Companies where Heyman Tomas J. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 6 | Dec 9, 2025 |
| EXEL | Exelixis, Inc. | 5 | May 29, 2026 |
| OPTN | Optinose, Inc. | 4 | May 21, 2025 |
| IVVD | Invivyd, Inc. | 2 | May 25, 2023 |
| XLO | Xilio Therapeutics, Inc. | 1 | Jun 13, 2023 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|